Kouchakji Elias 4
4 · FIBROGEN INC · Filed Jun 20, 2019
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Kouchakji Elias
SVP, Clinical Dev, Drug Safety
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2019-06-18−16,000→ 7,082 totalExercise: $14.57Exp: 2024-03-19→ Common Stock (16,000 underlying) - Exercise/Conversion
Common Stock
2019-06-18$14.57/sh+16,000$233,200→ 112,072 total
Footnotes (1)
- [F1]Fully vested.